Biotech · Private company
Totus Medicines
Track this companyFree. Adds Totus Medicines to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- FulvestrantPhase 1 · HR+/HER2-negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- PalbociclibPhase 1 · HR+/HER2-negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- RibociclibPhase 1 · HR+/HER2-negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- TOS-358Phase 1 · HR+/HER2-negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast CancerPHASE1 · RECRUITING · started Feb 15, 2023ClinicalTrials.gov NCT05683418 · fetched Nov 12, 2026